Daily Cardiology episodes:

• January 14, 2022How to reduce the atherosclerotic cardiovascular risk

  A case-based Review on HTN and DLP management

  ...more

  

  ---

• January 14, 2022DiaBeat: The Beating Heart of Diabetes (1st session)

  1st Diabetes Masterclass for Cardiologists

  ...more

  

  ---

• January 14, 2022PCSK9 inhibitors place in patients with cardiometabolic diseases

  PCSK9 inhibitors from two perspectives of Endocrinologist & Cardiologist

  ...more

  

  ---

• January 14, 2022Residents’ Island: Abidi CVD Prevention Academy

  Multidisciplinary approach to CVD Prevention

  ...more

  

  ---

• January 13, 2022Cardiometabolic Grand Round (3)

  A brief talk on DM medication challenges in patients with CVD

  ...more

  

  ---

• January 13, 20227th Case: Thrombocytopenia

  Any Concerns for OACs Use in Patients with Thrombocytopenia

  ...more

  

  ---

• January 13, 20225th Case: Stable ASCVD

  Low dose Rivaroxaban in SIHD, COMPASS trial

  ...more

  

  ---

• January 13, 20226th Case: Hepatic Impairment

  OAC of choice in patients with hepatic impairment, any difference between DOACs?

  ...more

  

  ---

• January 13, 20228th Case: Intracranial Bleed

  OAC Choice in High Thrombotic Risk Patients after ICH

  ...more

  

  ---

• January 13, 202210th Case: Drug Drug Interactions

  DOACs important interactions in clinical practice

  ...more

  

  ---